← Leaderboards
Alexander Lin
University Of Pennsylvania
$3,747,658
Attributed
$7,730,873
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2014–25$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,167,622 · 4
By mechanism
P01$9,436,749 · 1
U01$4,850,257 · 1
R01$2,880,616 · 2
Top collaborators
- Constantinos Koumenis5 shared
- Amit Maity5 shared
- Patricia M Corby4 shared
- Jie Deng1 shared
- Barbara A Murphy1 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Stephen Raymond Thom$6,841,868
- Constantinos Koumenis$17,144,115
- Amit Maity$4,832,230
- Ara A Chalian$0
- Leslie Eric Silberstein$41,598,995
Others in their field
Top investigators on “Toxic Effect”
- George R Seage · Abt Associates, Inc.$224,114,540
- Peter C Adamson · National Childhood Cancer Foundation$126,756,857
- Gregory H Reaman · National Childhood Cancer Foundation$123,836,183
- Carol Nesel · Westat$116,355,411
- Mary M Horowitz · Medical College Of Wisconsin$90,165,506
- Barney Sparrow · Battelle Memorial Institute$88,494,220
Research focus
Toxic EffectMalignant NeoplasmsClinical TrialsLeadAffectRadiation TherapyResponseRadiationQuality Of LifeFutureTumorDoseOxygenTreatment PlanningCellsTissuesPre-Clinical ModelHypoxiaMonitorScanningBiological MarkersClinicMalignant Neoplasm Of LungInflammation
Grant awards (15)
Translational Studies in FLASH Particle Radiotherapy$2,177,692
P01 · FY2025 · CA
Placebo-Controlled Phase II Randomized Clinical Trial of Photobiomodulation Therapy in Head and Neck Cancer Survivors with Chronic Lymphedema$706,669
R01 · FY2025 · CA
Translational Studies in FLASH Particle Radiotherapy$2,297,298
P01 · FY2024 · CA
Translational Studies in FLASH Particle Radiotherapy$92,007
P01 · FY2024 · CA
Translational Studies in FLASH Particle Radiotherapy$2,391,268
P01 · FY2023 · CA
Translational Studies in FLASH Particle Radiotherapy$2,478,484
P01 · FY2022 · CA
ARMOR Trial$661,000
U01 · FY2021 · DE
ARMOR Trial$1,473,147
U01 · FY2020 · DE
ARMOR Trial$1,479,702
U01 · FY2019 · DE
ARMOR Trial$1,236,408
U01 · FY2018 · DE
Using 18F-EF5 PET to measure hypoxia modulation by Nelfinavir in larynx cancer$351,104
R01 · FY2018 · CA
Using 18F-EF5 PET to measure hypoxia modulation by Nelfinavir in larynx cancer$393,811
R01 · FY2017 · CA
Using 18F-EF5 PET to measure hypoxia modulation by Nelfinavir in larynx cancer$488,805
R01 · FY2016 · CA
Using 18F-EF5 PET to measure hypoxia modulation by Nelfinavir in larynx cancer$488,805
R01 · FY2015 · CA
Using 18F-EF5 PET to measure hypoxia modulation by Nelfinavir in larynx cancer$451,422
R01 · FY2014 · CA